Seminars in Hematology
Volume 42, Issue 3 , Pages 165-168, July 2005

Pathophysiology of Hemolytic Transfusion Reactions

  • Robertson D. Davenport

      Affiliations

    • Corresponding Author InformationAddress correspondence to Robertson Davenport, MD, Department of Pathology, The University of Michigan Medical School, University Hospital 2G332/0054, 1500 E Medical Center Dr, Ann Arbor, MI 48109-0054.

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI.

Hemolytic transfusion reactions (HTR) are systemic reactions provoked by immunologic red blood cell (RBC) incompatibility. Clinical and experimental observations of such reactions indicate that they proceed through phases of humoral immune reaction, activation of phagocytes, productions of cytokine mediators, and wide-ranging cellular responses. HTR have many features in common with the systemic inflammatory response syndrome (SIRS). Knowledge of the pathophysiologic mechanisms in HTR suggest that newer biological agents that target complement intermediates or proinflammatory cytokines may be effective agents in the treatment of severe HTRs.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0037-1963(05)00059-4

doi:10.1053/j.seminhematol.2005.04.006

Seminars in Hematology
Volume 42, Issue 3 , Pages 165-168, July 2005

Article Tools

* Image Usage & Resolution